Deborah Luxenberg

7.3k total citations · 4 hit papers
20 papers, 6.1k citations indexed

About

Deborah Luxenberg is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Deborah Luxenberg has authored 20 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Deborah Luxenberg's work include T-cell and B-cell Immunology (10 papers), Immune Cell Function and Interaction (6 papers) and Psoriasis: Treatment and Pathogenesis (5 papers). Deborah Luxenberg is often cited by papers focused on T-cell and B-cell Immunology (10 papers), Immune Cell Function and Interaction (6 papers) and Psoriasis: Treatment and Pathogenesis (5 papers). Deborah Luxenberg collaborates with scholars based in United States, Canada and Hungary. Deborah Luxenberg's co-authors include Mary Collins, Lynette A. Fouser, Kyriaki Dunussi‐Joannopoulos, Spencer C. Liang, Xiangyang Tan, Beatriz M. Carreno, Rodney M. Hewick, David I. Israel, Shannon Kelly and Frann Bennett and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Deborah Luxenberg

20 papers receiving 5.8k citations

Hit Papers

Interleukin (IL)-22 and IL-17 are coexpre... 1985 2026 1998 2012 2006 1985 1988 1993 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Luxenberg United States 16 3.5k 1.4k 1.1k 635 565 20 6.1k
Sara A. Michie United States 41 2.3k 0.7× 1.3k 1.0× 632 0.6× 165 0.3× 941 1.7× 86 5.2k
Marjolein van Egmond Netherlands 45 3.5k 1.0× 1.8k 1.3× 1.4k 1.3× 280 0.4× 259 0.5× 126 6.8k
Giovanni Pizzolo Italy 58 4.9k 1.4× 2.1k 1.5× 2.6k 2.4× 192 0.3× 403 0.7× 283 11.9k
Guttorm Haraldsen Norway 39 4.4k 1.3× 1.6k 1.2× 1.6k 1.4× 145 0.2× 441 0.8× 89 7.2k
Michael D. Rosenblum United States 36 4.0k 1.2× 1.4k 1.0× 2.2k 2.0× 208 0.3× 313 0.6× 74 6.5k
Hans‐Jörg Bühring Germany 49 3.2k 0.9× 2.0k 1.5× 1.2k 1.1× 216 0.3× 308 0.5× 144 7.4k
Adrien Kissenpfennig United Kingdom 46 4.7k 1.4× 2.4k 1.7× 717 0.7× 267 0.4× 219 0.4× 83 8.1k
Michio Tomura Japan 40 3.9k 1.1× 1.5k 1.1× 1.4k 1.3× 196 0.3× 227 0.4× 90 5.7k
Muzlifah Haniffa United Kingdom 37 3.2k 0.9× 1.3k 1.0× 900 0.8× 142 0.2× 228 0.4× 89 5.7k
Ryuji Suzuki Japan 35 2.1k 0.6× 929 0.7× 984 0.9× 126 0.2× 263 0.5× 160 4.9k

Countries citing papers authored by Deborah Luxenberg

Since Specialization
Citations

This map shows the geographic impact of Deborah Luxenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Luxenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Luxenberg more than expected).

Fields of papers citing papers by Deborah Luxenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Luxenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Luxenberg. The network helps show where Deborah Luxenberg may publish in the future.

Co-authorship network of co-authors of Deborah Luxenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Luxenberg. A scholar is included among the top collaborators of Deborah Luxenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Luxenberg. Deborah Luxenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kovaleva, Marina, Jiquan Zhang, John Steven, et al.. (2018). Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis. Journal of Immunology Research. 2018. 1–13. 11 indexed citations
2.
Zhong, Xiaotian, Elizabeth Kieras, Eric Sousa, et al.. (2012). Pyroglutamate and O-Linked Glycan Determine Functional Production of Anti-IL17A and Anti-IL22 Peptide-Antibody Bispecific Genetic Fusions. Journal of Biological Chemistry. 288(2). 1409–1419. 15 indexed citations
3.
Geoghegan, Kieran F., Xi Song, Lise R. Hoth, et al.. (2012). Unexpected mucin-type O-glycosylation and host-specific N-glycosylation of human recombinant interleukin-17A expressed in a human kidney cell line. Protein Expression and Purification. 87(1). 27–34. 13 indexed citations
4.
Wright, Jill F., Frann Bennett, Jonathan Brooks, et al.. (2008). The Human IL-17F/IL-17A Heterodimeric Cytokine Signals through the IL-17RA/IL-17RC Receptor Complex. The Journal of Immunology. 181(4). 2799–2805. 238 indexed citations
5.
Cummins, Emma, Deborah Luxenberg, Fionnuala McAleese, et al.. (2008). A simple high-throughput purification method for hit identification in protein screening. Journal of Immunological Methods. 339(1). 38–46. 16 indexed citations
6.
Wu, Paul W., Jing Li, Sreekumar Kodangattil, et al.. (2008). IL-22R, IL-10R2, and IL-22BP Binding Sites Are Topologically Juxtaposed on Adjacent and Overlapping Surfaces of IL-22. Journal of Molecular Biology. 382(5). 1168–1183. 53 indexed citations
7.
Wu, Paul W., Jing Li, Sreekumar Kodangattil, et al.. (2008). 223 IL-22R, IL-10R2 and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22. Cytokine. 43(3). 292–292. 2 indexed citations
8.
Wright, Jill F., Yongjing Guo, Amira Quazi, et al.. (2007). Identification of an Interleukin 17F/17A Heterodimer in Activated Human CD4+ T Cells. Journal of Biological Chemistry. 282(18). 13447–13455. 255 indexed citations
9.
Liang, Spencer C., Xiangyang Tan, Deborah Luxenberg, et al.. (2006). Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. The Journal of Experimental Medicine. 203(10). 2271–2279. 1859 indexed citations breakdown →
10.
Carter, Laura, Michael W. Leach, Mihai L. Azoitei, et al.. (2006). PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology. 182(1-2). 124–134. 156 indexed citations
11.
Stephens, Geoffrey L., Rebecca S. McHugh, Matthew J. Whitters, et al.. (2004). Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells. The Journal of Immunology. 173(8). 5008–5020. 393 indexed citations
12.
Ling, Vincent, Paul W. Wu, Vikki Spaulding, et al.. (2003). Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss. Genomics. 82(3). 365–377. 145 indexed citations
13.
Bennett, Frann, Deborah Luxenberg, Vincent Ling, et al.. (2003). Program Death-1 Engagement Upon TCR Activation Has Distinct Effects on Costimulation and Cytokine-Driven Proliferation: Attenuation of ICOS, IL-4, and IL-21, But Not CD28, IL-7, and IL-15 Responses. The Journal of Immunology. 170(2). 711–718. 238 indexed citations
14.
Carreno, Beatriz M., Frann Bennett, Thu Chau, et al.. (2000). CTLA-4 (CD152) Can Inhibit T Cell Activation by Two Different Mechanisms Depending on Its Level of Cell Surface Expression. The Journal of Immunology. 165(3). 1352–1356. 216 indexed citations
15.
Baroja, Miren L., Deborah Luxenberg, Thu Chau, et al.. (2000). The Inhibitory Function of CTLA-4 Does Not Require Its Tyrosine Phosphorylation. The Journal of Immunology. 164(1). 49–55. 71 indexed citations
16.
Ling, Vincent, et al.. (1997). Structural identification of the hematopoietic progenitor antigen ER‐MP12 as the vascular endothelial adhesion molecule PECAM‐1 (CD31). European Journal of Immunology. 27(2). 509–514. 43 indexed citations
17.
Israel, David I., et al.. (1993). Bone Morphogenetic Protein-2 Causes Commitment and Differentiation in C3Hl0T1/2 and 3T3 Cells. Growth Factors. 9(1). 57–71. 427 indexed citations breakdown →
18.
Toriumi, Dean M., et al.. (1991). Mandibular Reconstruction With a Recombinant Bone-Inducing Factor: Functional, Histologic, and Biomechanical Evaluation. Archives of Otolaryngology - Head and Neck Surgery. 117(10). 1101–1112. 307 indexed citations
19.
Rosen, Vicki, et al.. (1988). Purification and characterization of other distinct bone-inducing factors.. Proceedings of the National Academy of Sciences. 85(24). 9484–9488. 526 indexed citations breakdown →
20.
Wong, Gordon, Patricia A. Temple, Deborah Luxenberg, et al.. (1985). Human GM-CSF: Molecular Cloning of the Complementary DNA and Purification of the Natural and Recombinant Proteins. Science. 228(4701). 810–815. 1079 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026